BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

10 articles for R Webster

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Medicinal chemistry approaches to avoid aldehyde oxidase metabolism.EBI
Pfizer
The discovery of indole-derived long acting beta2-adrenoceptor agonists for the treatment of asthma and COPD.EBI
Pfizer
The discovery of long acting beta2-adrenoreceptor agonists.EBI
Pfizer
Inhalation by design: novel ultra-long-actingß(2)-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist headgroup.EBI
Pfizer
Pyrazole NNRTIs 4: selection of UK-453,061 (lersivirine) as a development candidate.EBI
Pfizer
Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.EBI
Pfizer
Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.EBI
Pfizer
Discovery of a Series of Pyrimidine Carboxamides as Inhibitors of Vanin-1.EBI
Pfizer
Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX.BDB
University of Namur
Synthesis and biological evaluation of 1-aryl-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of cyclin-dependent kinases.BDB
Bristol-Myers Squibb